Drug Shortage Report for KETALAR
Report ID | 150702 |
Drug Identification Number | 00224405 |
Brand name | KETALAR |
Common or Proper name | KETALAR 50MG |
Company Name | SEARCHLIGHT PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | KETAMINE |
Strength(s) | 50MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
Packaging size | VIAL 10ML |
ATC code | N01AX |
ATC description | ANESTHETICS, GENERAL |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2021-12-10 |
Actual start date | |
Estimated end date | 2022-01-31 |
Actual end date | 2022-03-03 |
Shortage status | Resolved |
Updated date | 2022-03-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1600 RUE NOTRE DAME OUEST, SUITE 312 MONTREAL, QUEBEC CANADA H3J 1M1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2022-03-08 | French | Compare |
v4 | 2022-03-08 | English | Compare |
v3 | 2021-12-11 | English | Compare |
v2 | 2021-12-08 | French | Compare |
v1 | 2021-12-08 | English | Compare |
Showing 1 to 5 of 5